Flow cytometry in the diagnosis of cancer.
Flow cytometry has rapidly expanded from basic research to clinical laboratories mainly due to its unique characteristics regarding cell analysis. Among the clinical uses of flow cytometry cancer represents one of the most relevant. Several applications of flow cytometry can currently be applied to the study of cancer, including the detection of tumour cell DNA aneuploidy, the analysis of tumour cell proliferation and the immunophenotyping of leukemias. Although standardized flow cytometry protocols for these applications are scanty, the clinical value has been clearly established. The presence of DNA aneuploidy and a high proportion of S-phase tumour cells have been associated with tumour malignancy and a poor prognosis. The immunophenotype of leukaemia is of great help both for the diagnosis and classification of chronic lymphoproliferative disorders and acute leukaemias, especially in acute lymphoblastic leukemia cases and the M0, M3-variant, M6 and M7 acute myeloblastic leukaemia subtypes. In addition, it allows the identification of relatively rare leukemia cases such as the biphenotypic and the Nk-cell lineage leukemias. The development of flow cytometry is continuously bringing new applications into the clinical laboratory in the area of cancer diagnosis.
Orfao
A
A
Servicio General de Citometria, University of Salamanca, Spain.
Ciudad
J
J
Gonzalez
M
M
Lopez
A
A
del Mar Abad
M
M
Paz Bouza
J I
JI
Cruz
J J
JJ
Gomez Alonso
A
A
San Miguel
J F
JF
D005434:Flow Cytometry; D006801:Humans; D009369:Neoplasms / Q000175:diagnosis*